Could the Cure for IBD Be Inside Your Mouth?

A new study describes how poor oral health may worsen gut inflammation.

11:29 AM

Author | Kelly Malcom

white teeth floating in background of red GI tract on teal blue background
Image created by Stephanie King.

While many people put off their regular trips to the dentist, recent research has shown that the consequences of doing so may go beyond cavities and root canals. From heart disease to diabetes, poor oral health is often a reflection of a person's overall health and may even be the cause of systemic disease.

A new collaborative study from the U-M Medical and Dental Schools reveals that inflammatory bowel disease (IBD), which included Crohn's disease and ulcerative colitis and afflicts an estimated 3 million adults in the U.S., may be the latest condition made worse by poor oral health.

Nobuhiko Kamada, Ph.D., assistant professor of internal medicine in the division of gastroenterology, has been studying the gut microbiome—the collection of bacteria that are normally present in the gut— for years. He noted an emerging link in research literature between an overgrowth of foreign bacterial species in the guts of people with IBD—bacteria that are normally found in the mouth. "I decided to approach the dental school to ask the question, does oral disease affect the severity of gastrointestinal diseases?" says Kamada.

The new mouse study, published in Cell, shows two pathways by which oral bacteria appear to worsen gut inflammation.

In the first pathway, periodontitis, the scientific name for gum disease, leads to an imbalance in the normal healthy microbiome found in the mouth, with an increase of bacteria that cause inflammation. These disease-causing bacteria then travel to the gut.

However, this alone may not be enough to set off gut inflammation. The team demonstrated that oral bacteria may aggravate gut inflammation by looking at microbiome changes in mice with inflamed colons.

MORE FROM THE LAB: Subscribe to our weekly newsletter

"The normal gut microbiome resists colonization by exogenous, or foreign, bacteria," says Kamada. "However, in mice with IBD, the healthy gut bacteria are disrupted, weakening their ability to resist disease-causing bacteria from the mouth."  The team found that mice with both oral and gut inflammation had significantly increased weight loss and more disease activity.

In the second proposed pathway, periodontitis activates the immune system's T cells in the mouth. These mouth T cells travel to the gut where they, too, exacerbate inflammation. The gut's normal microbiome is held in balance by the action of inflammatory and regulatory T cells that are fine-tuned to tolerate the resident bacteria. But, says Kamada, oral inflammation generates mostly inflammatory T cells that migrate to the gut, where they, removed from their normal environment, end up triggering the gut's immune response, worsening disease.

"This exacerbation of gut inflammation driven by oral organisms that migrate to the gut has important ramifications in emphasizing to patients the critical need to promote oral health as a part of total body health and wellbeing," says co-author William Giannobile, DDS, the William K and Mary Anne Najjar professor of dentistry and chair of the department of periodontics and oral medicine at the U-M School of Dentistry.

The study has implications for novel treatments for IBD, necessary because "far too many patients still fail medications, leading to reduced quality of life and eventual surgery," says study co-author Shrinivas Bishu, M.D., assistant professor of gastroenterology. "This study importantly implies that clinical outcomes in IBD may be improved by monitoring oral inflammation – an intriguing concept."

Paper cited: "The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis," CellDOI: 10.1016/j.cell.2020.05.048

Like Podcasts? Add the Michigan Medicine News Break to your Alexa-enabled device or subscribe for updates on iTunesGoogle Play and Stitcher.


More Articles About: Lab Report Basic Science and Laboratory Research Oral Surgery & Dentistry Inflammatory Bowel Disease (IBD) Crohn's and Colitis Crohn's Disease All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories white pills falling out of orange pill bottle on a brown surface
Health Lab
Drug combination reduces breast cancer risk and improves metabolic health in rats
Researchers investigated the combined effects of bazedoxifene and conjugated estrogens in rat models as an alternative to tamoxifen.
RNA strand in purple on black background
Health Lab
A structural biologist weighs in on the tricky task of determining RNA’s shape
A recent article in Nature details why the quest to determine the shapes of RNA is difficult even for artificial intelligence.
mouse seeing three cookies with red dots out of brain
Health Lab
Researchers use nanoparticles to target glioblastoma in mice
University of Michigan researchers have created nanodiscs that can target cholesterol levels in GBM, starving the cancer cells and increasing survival rates of the treated mice.
doctors drawn looking at big oversized lungs
Health Lab
The most effective prevention method for complications post lung transplant
Out of the two most common treatments for chronic lung allograft dysfunction, a condition that can form after lung transplantation that has no treatment, a study from University of Michigan Health found that cyclosporine is not as effective as tacrolimus in preventing the condition.
blood vessel up close with red cells and yellow inside
Health Lab
Drug candidate successfully treats atherosclerosis, fatty liver disease in large mammals 
A compound that was previously found to treat severe fatty liver disease also reduces atherosclerosis, a primary driver of cardiovascular death, in non-human primates. The drug candidate was developed at the University of Michigan.
ultrasound scan on yellow background with red dot found in two images
Health Lab
Using ultrasound technology to quickly diagnose giant cell arteritis
Ultrasound technology at University of Michigan Health is helping diagnose giant cell arteritis in patients to begin potentially moving away from using invasive surgical biopsy methods.